HiFiBiO SAS To Report Results From The First Fully Integrated, Single-Cell Antibody Discovery Platform At IBC Antibody And Engineering Therapeutics 2015 Conference

CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)--HiFiBiO SAS today announced that the latest results from their CelliGOTM platform will be presented by Chief Scientific Officer, Dr. Allan Jensen, 7-10 San Diego, California. The presentation, will be on Tuesday, Dec. 8 at 13:45 (PST) and will feature important case studies and new data.

MORE ON THIS TOPIC